Hubei Haosun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is FLUMAZENIL, with a corresponding US DMF Number 17971.
Remarkably, this DMF maintains an Active status since its submission on December 12, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 16, 2014, and payment made on January 06, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II